Posted by Michael Wonder on 11 May 2017
European Commission grants approval for Merck’s new Pergoveris pen for fertility treatment
10 May 2017 - With this approval, Pergoveris becomes the first product with a combination of FSH and LH hormones in a ready-to-use liquid version.
Merck today announced that the European Commission has granted approval for the new Pergoveris Pen, addressing an unmet medical need by providing an improved, convenient and ready-to-use fertility combination treatment option for women with severe follicle stimulating hormone and luteinizing hormone deficiency.
